Organisation paid for research Program year 2023 Source: CMS Open Payments

Benchmark Research Fort Worth

Neither a doctor nor a teaching hospital

Research payments

$860,916

109 payments

Through program year 2023, Benchmark Research Fort Worth is reported as receiving $860,916 in research payments, across 109 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2023	Research	$860,405	107
2022	Research	$511	2

Breakdown

Who paid Research payments · program years 2022–2023

Moderna TX, Inc. $860,916 109 payments

Studies the money was for Research payments · program years 2022–2023

A Phase 2/3 Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 Variants $422,273 42 payments
A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older $162,097 25 payments
Phase 1/2, randomized, observer-blind to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1073 and co-administered mRNA-1273 and mRNA-1010 vaccines compared to mRNA-1273 and mRNA-1010 vaccines along in healthy adults 18 to 75 years $114,676 13 payments
A Phase 1, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 18- to 30-year-old Healthy Adults $78,376 14 payments
A Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose Confirmation Study to Evaluate the Safety, Tolerability, and Immunogenicity of Lyophilized Zika Vaccine mRNA-1893 in Adults Aged 18-65 Years and Living in Endemic and Non Endemic Flavivi $64,683 10 payments
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age $18,300 3 payments
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older $511 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.